AsiaMedic Limited (SGX:505)
Singapore · Delayed Price · Currency is SGD 0.0180
-0.0010 (-5.26%)
At close: Sep 11, 2026
AsiaMedic Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 21 | 19 | 13 | 15 | 13 | 18 | |
Market Cap Growth | 7.60% | 51.20% | -15.38% | 11.72% | -25.00% | -20.00% |
Enterprise Value | 31 | 33 | 14 | 14 | 12 | 17 |
Last Close Price | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 10.50 | 9.49 | 12.58 | 7.81 | 6.15 | 25.05 |
PS Ratio | 0.59 | 0.54 | 0.44 | 0.63 | 0.71 | 0.97 |
PB Ratio | 1.13 | 1.06 | 0.75 | 1.13 | 1.23 | 2.05 |
P/TBV Ratio | 1.28 | 1.20 | 0.89 | 1.14 | 1.23 | 2.18 |
P/FCF Ratio | 5.45 | 15.97 | 18.81 | 15.27 | 57.39 | 5.86 |
P/OCF Ratio | 4.72 | 4.95 | 5.12 | 4.40 | 10.89 | 5.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.89 | 0.93 | 0.49 | 0.60 | 0.61 | 0.93 |
EV/EBITDA Ratio | 6.69 | 20.92 | 10.68 | 8.90 | 9.80 | 14.57 |
EV/EBIT Ratio | 18.86 | 48.96 | 22.12 | 19.78 | 12.61 | 21.46 |
EV/FCF Ratio | 8.15 | 27.15 | 21.14 | 14.48 | 49.78 | 5.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.91 | 0.99 | 1.25 | 0.71 | 0.67 | 0.69 |
Debt / EBITDA Ratio | 3.98 | 4.41 | 6.79 | 3.38 | 3.72 | 2.93 |
Debt / FCF Ratio | 4.38 | 14.86 | 31.32 | 9.59 | 31.26 | 1.98 |
Net Debt / Equity Ratio | 0.45 | 0.45 | 0.57 | -0.01 | -0.12 | -0.39 |
Net Debt / EBITDA Ratio | 3.98 | 5.24 | 7.24 | -0.09 | -1.10 | -2.93 |
Net Debt / FCF Ratio | 2.15 | 6.80 | 14.33 | -0.15 | -5.57 | -1.12 |
Asset Turnover | 0.82 | 0.79 | 0.77 | 0.90 | 0.87 | 1.00 |
Inventory Turnover | 141.55 | 113.14 | 68.61 | 59.06 | 57.63 | 54.52 |
Quick Ratio | 2.17 | 1.94 | 1.70 | 1.83 | 2.21 | 2.13 |
Current Ratio | 2.25 | 2.10 | 1.88 | 2.08 | 2.57 | 2.47 |
Return on Equity (ROE) | 11.69% | 8.16% | 4.28% | 15.88% | 22.20% | 8.52% |
Return on Assets (ROA) | 1.74% | 0.93% | 1.06% | 1.71% | 2.63% | 2.69% |
Return on Capital Employed (ROCE) | 3.50% | 1.90% | 1.70% | 3.20% | 5.00% | 5.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 10, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 9.64% | 10.54% | 7.95% | 12.80% | 16.27% | 3.99% |
FCF Yield | 18.35% | 6.26% | 5.32% | 6.55% | 1.74% | 17.07% |
Buyback Yield / Dilution | -1.48% | -0.05% | -1.97% | -1.13% | - | -2.36% |